CG
Clinton Group’s Bio-Rad Laboratories Class A BIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-7,731
| Closed | -$1.93M | – | 363 |
|
|
2018
Q1 | $1.93M | Sell |
7,731
-38,733
| -83% | -$9.68M | 0.21% | 153 |
|
|
2017
Q4 | $11.1M | Buy |
46,464
+36,677
| +375% | +$8.75M | 0.97% | 4 |
|
|
2017
Q3 | $2.18M | Sell |
9,787
-4,668
| -32% | -$1.04M | 0.24% | 128 |
|
|
2017
Q2 | $3.27M | Buy |
14,455
+13,394
| +1,262% | +$3.03M | 0.33% | 101 |
|
|
2017
Q1 | $212K | Buy |
+1,061
| New | +$212K | 0.01% | 857 |
|
|
2016
Q3 | – | Sell |
-6,005
| Closed | -$859K | – | 906 |
|
|
2016
Q2 | $859K | Buy |
+6,005
| New | +$859K | 0.04% | 530 |
|
|
2016
Q1 | – | Sell |
-1,955
| Closed | -$271K | – | 863 |
|
|
2015
Q4 | $271K | Sell |
1,955
-2,151
| -52% | -$298K | 0.02% | 658 |
|
|
2015
Q3 | $551K | Buy |
+4,106
| New | +$551K | 0.05% | 420 |
|
|
2015
Q1 | – | Sell |
-3,460
| Closed | -$417K | – | 480 |
|
|
2014
Q4 | $417K | Buy |
3,460
+1,581
| +84% | +$191K | 0.13% | 274 |
|
|
2014
Q3 | $213K | Sell |
1,879
-318
| -14% | -$36K | 0.09% | 333 |
|
|
2014
Q2 | $263K | Buy |
+2,197
| New | +$263K | 0.13% | 260 |
|